#antiretrovirals

A study finds that CD4 cells decline after people with HIV contract hepatitis C.

Treatment efficacy has steadily improved since effective combination HIV therapy first entered advanced clinical trials in the mid-1990s.

A look at 2009 to 2014 data found that those in care for HIV saw a considerable fall in treatment deferrals.

More than 250,000 people living with HIV would be affected by a proposed rule change to Medicare Part D.

Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.

Periodic infusions of long-acting HIV antibodies may eventually become a new way of treating the virus.

In a move to cut Medicare costs, the proposed changes would also affect people with cancer, depression and schizophrenia.

Today’s HIV meds are not linked to this common condition.

Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), analyzes data from a 2018 UNAIDS report.

The Impact of Hurricane Maria on HIV

The single-tablet antiretroviral regimen includes Janssen’s darunavir plus Gilead’s cobicistat, emtricitabine and tenofovir alafenamide.

Whites have a higher rate of successful HIV treatment.

Research found that healthcare providers could do better at preventing drug interactions.